I have openly challenged Kent Ertugrul, Phorm CEO to publish a verifiable legal opinion confirming his product’s compliance with UK and EU law. Over a year later I am still waiting for his response. I have written a lot about Phorm here. And will continue to.
Phorm’s share price has fallen from 3505p on February 25th 2008 to 98p at end of business today.